The Japanese Ministry of Health, Labour and Welfare has approved TAS-102 (trifluridine/tipiracil; Lonsurf) for the treatment of patients with unresectable advanced or recurrent gastric cancer that has progressed after chemotherapy.
Led by Johanna Bendell, MD, panelists Ian Chau, MD; Yelena Y. Janjigian, MD; Manish A. Shah, MD; and Kohei Shitara, MD, focus on sequencing decisions for patients with gastroesophageal cancers. View Now
Paul G. Richardson, MD, clinical program leader and director of clinical research, Jerome Lipper Multiple Myeloma Center, and institute physician, Dana-Farber Cancer Institute, discusses new directions in multiple myeloma. View now